Skip to main content
Search
search
Link to Facebook page
Link to X
Link to YouTube channel
Link to flipboard
Link to RSS
Main navigation
Home
About
About ACSH
Financials
Our Team
Video
Donate
Publications
Media/Contact
Subscribe
Write For Us
risk vs. benefit
email
facebook
twitter
linkedin
pocket
reddit
print
4 Prescription Drugs People Love
In 2019, I wrote an article called "4 Prescription Drugs People Hate." It was rather popular.
Read more
Non-Opioid Drugs That Can Be Dangerous and Habituating. Should We Ban Them?
Just about any drug can be made to look bad, especially when its risks are considered in the absence of its benefits.
Read more
Subscribe to risk vs. benefit
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
There are Lots of Longevity Regimens. One Stands out for Me
Human Brain Cells Taught to Play Doom. Seriously.
March Madness, Medical Edition: Public Health’s Sweet Sixteen
Ultra-Processed Panic: From Data to Drama in 100 Words
Five Facts to Know About Glyphosate Right Now
ACSH Podcasts
Podcast: Some People Can't Enjoy Music. Science Has An Explanation
Podcast: What's Radiation Therapy for Cancer Really Like? An Expert (And Patient) Explains
Podcast: You May (But Probably Won't) Benefit From Fish Oil Supplements
Podcast: Kīlauea Eruption—The Nasty Volcanic Chemical You Definitely Shouldn't Breathe
Podcast: 'No Magic Fix': Artificial Sweeteners Won't Save Your Life—But Won't Kill You Either
More podcasts
Latest from Josh
Human Brain Cells Taught to Play Doom. Seriously.
Can Drugs Beat Stage Fright?
Casey Means' Senate Testimony: Evasion and Doubletalk
Seed Oil Soap? Tallow Soap? Which Makes the Better Breakfast?
More articles
Latest from Chuck
March Madness, Medical Edition: Public Health’s Sweet Sixteen
From Asteroid Defense to Vaccines: The Economics of Public Safety
The AIgorithm That Said No
Ultra-Processed Panic: From Data to Drama in 100 Words
More articles